Aconitum Napellus Homeopathic Pills Fail Quality Test
Washington Homeopathic Products is recalling Aconitum napellus Fear pills in multiple potencies nationwide due to failed identification testing by high-performance thin-layer chromatography (HPTLC).
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II recall with no reported illnesses or injuries. The hazard is a failure of identity testing, which is a quality/labeling issue rather than evidence of contamination or physical harm. This meets the rubric criterion for moderate severity: minor labeling or quality errors without reported harm.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Aconitum nap Fear sucrose/lactose pills in various potencies (4X, 5X, 6X, 7X, 9X, 11X, 12X, 15X, 20X, 24X, and 30X) packaged in containers ranging from 1 oz to 4 oz. The recall affects approximately 562 bottles distributed nationwide.
The products are being recalled because they obtained out-of-specification test results during identification testing based on HPTLC (high-performance thin-layer chromatography) analysis. This indicates the products did not meet required quality standards for identification verification.
Consumers who have purchased these products should stop using them. The affected lot is #26198. More information is available from the FDA at https://www.fda.gov/drugs/drug-safety-and-availability/drug-recalls.
The recalled product
- Product
- Aconitum nap Fear* Sucrose/Lactose Pills HPUS: 4X, 5X, 6X,15X, packaged in 1 oz containers, Aconitum nap Fear* Sucrose/Lactose Pills HPUS: 4X, 7X, 12X, packaged in 2 dr containers, Aconitum nap Fear* Sucrose/Lactose Pills HPUS: 4X, 12X, 20X, packaged in 2 oz containers, Aconitum
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- quality-testing-failure
- identification-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 26198
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27